written by reader I placed a topic for discussion last night on a Texas biotech set to release an announcement on CD19

By backoffice, June 16, 2017

on June 23rd that look promising for big returns (according to the offer). I did some investigating and came up with $BLCM,
Bellicum Pharmaceuticals that also has an orphan drug in development. Maybe the Doc can give use some inside on this.

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.



This site uses Akismet to reduce spam. Learn how your comment data is processed.

Inline Feedbacks
View all comments
Travis Johnson, Stock Gumshoe
June 26, 2017 4:36 pm

Hello — yes, I covered it ten days ago or so, and Dr. KSS did comment on the stock as well following that note. You’re correct with Bellicum, at least according to my research.

Add a Topic
Add a Topic
👍 16581
June 26, 2017 6:55 pm

additional nfo???how to get to it—-confusing

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info